- Home
- SCOR vs SCNX Comparison
SCOR vs SCNX Comparison
Compare SCOR & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCOR | SCNX |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.6M | 15.5M |
| IPO Year | 2007 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SCOR | SCNX |
|---|---|---|
| Price | $7.18 | $0.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 6.3K | ★ 349.9K |
| Earning Date | 05-05-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 127.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $403,549,000.00 | $3,831,778.00 |
| Revenue This Year | $2.75 | $1,097.38 |
| Revenue Next Year | $7.30 | $239.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 1.02 | ★ 30.72 |
| 52 Week Low | $6.10 | $0.24 |
| 52 Week High | $10.18 | $2.60 |
Technical Indicators
Market Signals| Indicator | SCOR | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 64.78 |
| Support Level | $6.88 | $0.37 |
| Resistance Level | $7.80 | $0.48 |
| Average True Range (ATR) | 0.40 | 0.03 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 39.61 | 95.97 |
Price Performance
Historical ComparisonAbout SCOR comScore Inc.
comScore Inc is a information and analytics company that measures advertising, content, and the consumer audiences of each, across media platforms. It create products using a data platform that combines information on digital platforms (connected televisions, mobile devices, tablets and computers), televisions, direct to consumer applications, and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. Its segments include Content & Ad Measurement and Research & Insight Solutions of which the Content & Ad Measurement segment derives the majority of the revenue.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.